Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 21-30 of 149 (Search time: 0.016 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2008Dietary omega-3 fats for treatment of inflammatory joint disease: Efficacy and utilityProudman, S.; Cleland, L.; James, M.
2001Predictors of outcome in patients with oligoarthritis - Results of a protocol of intraarticular corticosteroids to all clinically active jointsGreen, M.; Marzo-Ortega, H.; Wakefield, R.; Astin, P.; Proudman, S.; Conaghan, P.; Hordon, L.; Emery, P.
2011Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohortNikpour, M.; Hissaria, P.; Byron, J.; Sahhar, J.; Micallef, M.; Paspaliaris, W.; Roddy, J.; Nash, P.; Sturgess, A.; Proudman, S.; Stevens, W.
2018Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestationsThakkar, V.; Patterson, K.; Stevens, W.; Wilson, M.; Roddy, J.; Sahhar, J.; Proudman, S.; Hissaria, P.; Nikpour, M.
2017Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritisWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; Mcwilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.
2015Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three yearsWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; McWilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.
2003A Biomarker of n-3 compliance in patients taking fish oil for rheumatoid arthritisCleland, L.; Proudman, S.; Hall, C.; Stamp, L.; McWilliams, L.; Wylie, N.; Neumann, M.; Gibson, R.; James, M.
2011Quantitation of total and free teriflunomide (A77 1726) in human plasma by LC-MS/MSRakhila, H.; Rozek, T.; Hopkins, A.; Proudman, S.; Cleland, L.; James, M.; Wiese, M.
2015Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung diseaseMoore, O.; Proudman, S.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Morrisroe, K.; Thakkar, V.; Sahhar, J.; Roddy, J.; Youssef, P.; Gabbay, E.; Nash, P.; Zochling, J.; Stevens, W.; Nikpour, M.
2017CD40L-dependent pathway is active at various stages of rheumatoid arthritis disease progressionGuo, Y.; Walsh, A.; Fearon, U.; Smith, M.; Wechalekar, M.; Yin, X.; Cole, S.; Orr, C.; McGarry, T.; Canavan, M.; Kelly, S.; Lin, T.; Liu, X.; Proudman, S.; Veale, D.; Pitzalis, C.; Nagpal, S.